Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2006
07/20/2006WO2005108949A3 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
07/20/2006WO2005103300A3 Pattern recognition method for diagnosis of systemic autoimmune diseases
07/20/2006WO2005096693A3 Cancer prognosis and/or diagnosis method
07/20/2006WO2005093103A3 Development and use of fluorescent probes of unbound analytes
07/20/2006WO2005089508A3 Dna sequence detection by limited primer extension
07/20/2006WO2005082073A3 Real-time polymerase chain reaction-based genotyping assay for chemokine receptor (cxcr2) single nucleotide polymorphism
07/20/2006WO2005062929A3 Use of fc receptor polymorphisms as diagnostics for treatment strategies for immune-response disorders
07/20/2006WO2005047509A3 The mycolactone locus : an assembly line for producing novel polyketides, with therapeutic and prophylatic uses
07/20/2006WO2004111197A3 Gene expression signatures, methods and compositions for diagnosing disorders of the lung
07/20/2006WO2004059280A3 Methods, compositions and kits for biomarker extraction
07/20/2006WO2004028352A3 Methods for prediction and prognosis of cancer, and monitoring cancer therapy
07/20/2006WO2003101177A3 Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions
07/20/2006WO2003083045A3 Lambda integrase mediated recombination in plants
07/20/2006WO2003066808A3 Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells
07/20/2006US20060162025 Expression cassettes for vascular tissue-preferential expression in plants
07/20/2006US20060162007 Bentgrass event asr-368 and compositions and methods for detection thereof
07/20/2006US20060162002 Drug screening; assaying for activators of the heat shock factor 1 (HSF-1) protein, which increases lifespan when overexpressed in an organism; antiaging agents
07/20/2006US20060161355 Computer-aided probability base calling for arrays of nucleic acid probes on chips
07/20/2006US20060160991 Genes and polypeptides relating to prostate cancers
07/20/2006US20060160835 Methods and compositions for treatment of central nervous system disorders
07/20/2006US20060160764 LIMKs as modifiers of p53 pathway and methods of use
07/20/2006US20060160762 Methods for the treatment, diagnosis, and prognosis of cancer
07/20/2006US20060160760 Modulation of glucocorticoid receptor expression
07/20/2006US20060160759 Influenza therapeutic
07/20/2006US20060160732 Compositions and methods for inhibiting cell senescence and hyperproliferative disorders
07/20/2006US20060160731 Peptide nucleic acids
07/20/2006US20060160728 Diagnostic and therapeutic use of ensandin-0138 gene and protein for neurodegenerative diseases
07/20/2006US20060160721 Method of plasma lipidation to prevent, inhibit and/or reverse atherosclerosis
07/20/2006US20060160700 Nadh-dependent cytochrome b5 reductase as target for herbicides
07/20/2006US20060160207 Cucurbituril derivative-bonded solid substrate and biochip using the same
07/20/2006US20060160187 Combinatorial interleukin-2 muteins
07/20/2006US20060160185 Methods of evaluating viral entry inhibitors using patient derived envelope protein constructs
07/20/2006US20060160184 Fab library for the preparation of anti VEGF and anti rabies virus fabs
07/20/2006US20060160183 Vaccines and immunotherapeutics derived from the human immunodeficiency virus (hiv) transactivator of transcription protein for the treatment and prevention of hiv disease
07/20/2006US20060160178 Methods of generating antibody diversity in vitro
07/20/2006US20060160171 Detection method and apparatus for detecting microbial growth
07/20/2006US20060160170 Method and device of rapid antigen extraction
07/20/2006US20060160169 Cell microarray for profiling of cellular phenotypes and gene function
07/20/2006US20060160168 Methods and products for identifying compounds that modulate cell plasma membrane repair
07/20/2006US20060160167 for assaying aspects of the renin-angiotensin system; suitable for automation and high-throughput screening assay design; analyzing the spectral data to identify the enzymatic activity products
07/20/2006US20060160166 Rapid triglyceride assay for use in pulp pitch control
07/20/2006US20060160165 Perfusion blood through channel coated with collagen; measure thrombosis and platelet aggregation ; prevent cardiovascular disorders
07/20/2006US20060160159 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
07/20/2006US20060160154 Materials and methods for detection and treatment of breast cancer
07/20/2006US20060160146 Method of screening compound affecting amyloid beta production
07/20/2006US20060160145 Assay that makes use of the interaction of early pregnancy factor (EPF) or an EPF-related peptide with a human dorsal root receptor (hDRR) or hDRR related receptor; also useful to determine whether the test compound is an agonist or antagonist of hDRRs
07/20/2006US20060160144 Sensor arrangement, device and method for testing active substances and/or active sites from a pharmacological point of view using an amperometer and/or potentiometer
07/20/2006US20060160140 Human nuclear receptor protein nNR7-1
07/20/2006US20060160131 Method for the identification of drug targets
07/20/2006US20060160130 Recombinant RSV virus expression systems and vaccines
07/20/2006US20060160129 Methods of producing a library and methods of selecting polynucleotides of interest
07/20/2006US20060160128 Novel adenosine deaminase homolog
07/20/2006US20060160127 Extraction of molecules using frame
07/20/2006US20060160126 90 human secreted proteins
07/20/2006US20060160125 Compositions and methods for nonenzymatic ligation of oligonucleotides and detection of genetic polymorphisms
07/20/2006US20060160124 Cationic, water-soluble polythiophene derivatives, which can readily transduce oligonucleotide hybridization into a clearly interpretable optical (colorimetric, fluorescent or luminescent) or electrical signal
07/20/2006US20060160123 For increasing stability of short interfering RNA molecule when in contact with biological sample, and reducing off-target effects/interferon responsiveness; ribonuclease stability
07/20/2006US20060160122 Polyelectrolyte-coated size-exclusion ion-exchange particles
07/20/2006US20060160121 Probe arrays for detecting multiple strains of different species
07/20/2006US20060160120 Novel hydrogel copolymer, substrate coated with the copolymer, method of producing microarray using the copolymer, and microarray produced by the method
07/20/2006US20060160119 Genetic screening for improving treatment of patients diagnosed with depression
07/20/2006US20060160118 Comprises muropeptides which activate nuclear factor kappa B; drug screening; inflammatory bowel diseases; Nucleotide sequences coding protein for use in the treatment of crohn's disease
07/20/2006US20060160117 Polynucleotide motor, a motor system, their preparation and uses
07/20/2006US20060160116 Repetitive sequence-free DNA libraries
07/20/2006US20060160115 Activation method of protein derived from extremely thermophilic bacterium in nucleic acid amplification reaction and use thereof
07/20/2006US20060160114 Reagents and methods for predicting drug resistance
07/20/2006US20060160113 Terminal-phosphate-labeled nucleotides
07/20/2006US20060160112 Tissue inhibitor of metalloproteinase (TIMP) as a marker and predictor of cardiovascular disease and both cardiac and non-cardiac mortality
07/20/2006US20060160111 Measuring forster resonance energy transfer with polarized and depolarized light
07/20/2006US20060160110 Methods of designing small interfering RNAs, antisense polynucleotides, and other hybridizing polynucleotides
07/20/2006US20060160108 Populations of reporter sequences and methods of their use
07/20/2006US20060160107 Testing for a compound that increases the amount of SDF-1 polypeptide or mRNA encoding the SDF-1 polypeptide in facilitatory cells (FCs); immunoassay
07/20/2006US20060160106 Using peptide nucleic acid probes to detect chromosome aberrations in eukaryotic cells
07/20/2006US20060160105 determining the sequence of alleles of a locus of interest, and quantitating a ratio for the alleles at said locus which indicates the presence or absence of a chromosomal abnormality; non-invasive method for fetal DNA testing
07/20/2006US20060160104 Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors
07/20/2006US20060160103 Mammalian neuralized family transcriptional regulators and uses
07/20/2006US20060160102 Identification of rare alleles by enzymatic enrichment of mismatched heteroduplexes
07/20/2006US20060160101 Inactivated FCV vaccines
07/20/2006US20060160100 Enzymatic electrochemical detection assay using protective monolayer and device therefor
07/20/2006US20060160099 Substrate preparation process
07/20/2006US20060160098 Polymeric label molecules
07/20/2006US20060160097 Amplification reaction vessel, and method of manufacturing the same
07/20/2006US20060160096 Nucleic acid labeling methods
07/20/2006US20060160095 Survivin
07/20/2006US20060160094 Determining appropriate treatment of a neoplasia by comparing a p53 gene or transcript in a human tumor sample to a wild-type p53 gene or a transcript having a size of 2.8 kb in normal human tissue and identifying the differences
07/20/2006US20060160093 Introduction of structural affinity handles as a tool in selective nucleic acid separations
07/20/2006US20060160092 useful for evaluating actin cytoskeleton-controlling agents; as a functional marker of the intercalate disc for heart diseases, such as myocardial infarction and myocarditis, due to its extremely high expression at the intercalate disc of cardiac muscle cells
07/20/2006US20060160091 Polynucleotides encoding a class II cytokine receptor
07/20/2006US20060160090 Composition splice variants and methods relating to cancer specific genes and proteins
07/20/2006US20060160089 Fixing agents, method of fixing substance with the same, and substrate having sustance fixed thereto with the same
07/20/2006US20060160088 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 40 (gpr40)
07/20/2006US20060160087 Monitoring and treatment of amyotrophic lateral sclerosis
07/20/2006US20060160086 Method for continuous detection of an analyte, trifunctional detecting reagent used and detecting device
07/20/2006US20060160085 Novel buffer formulations for isolating purifying and recovering long-chain and short-chain nucleic acids
07/20/2006US20060160084 Process for amplifying nucleic acid
07/20/2006US20060160083 Diagnositics and therapeutics for diseases associated with human g-protein couple receptor 14 (gpr14)
07/20/2006US20060160082 Novel genes and proteins encoded thereby
07/20/2006US20060160081 Labelled nucleotides
07/20/2006US20060160080 Avian sex determination method
07/20/2006US20060160079 Methods for the treatment of dementia based on apo e genotype